SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
DECODE GENETICS-*DCGN
An SI Board Since July 2000
Posts SubjectMarks Bans Symbol
313 31 0 DCGN
Emcee:  Secret_Agent_Man Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
238DCGN :Update From Analyst Day in Iceland 2006-06-27 15:11 (New York) Piper Jaffrmopgcw-7/12/2006
237deCODE Submits IND on DG051 for the Prevention of Heart Attack June 29, 2006 1LJM-6/29/2006
236deCODE Announces Positive Results From Preliminary Phase II Clinical Trial of CEnigel bates-6/26/2006
235deCODE Provides Product Development Update Monday June 26, 4:10 am ET Clinical Pnigel bates-6/26/2006
234deCODE Initiates Phase II Clinical Program for DG041 for Peripheral Artery Diseanigel bates-6/22/2006
233New breast cancer gene raises risk in Europeans June 19, 2006 15:39:35 (ET) (LJM-6/20/2006
232The BARD1 Cys557Ser Variant and Breast Cancer Risk in Iceland Simon N. Stacey1*nigel bates-6/20/2006
231<i>...“To give a sense of scale, our list price in the U.S. is about $900 nigel bates-5/23/2006
230deCODE Initiates Phase III Trial for DG031 for the Prevention of Heart Attack Wenigel bates-5/17/2006
229deCODE and Illumina Form Alliance to Develop and Commercialize DNA-based Diagnosnigel bates-5/15/2006
228deCODE Discovers Major Genetic Risk Factor for Prostate Cancer Sunday May 7, 1:2nigel bates-5/8/2006
227Nice! SPA and first dosing almost coincident. Gets the 10% back tomorrow.keokalani'nui-5/4/2006
226deCODE Announces Special Protocol Assessment Agreement with the FDA for Phase IInigel bates-5/3/2006
225Looking at the balance sheet, we're certainly 'leveraged' now... <nigel bates-5/2/2006
224deCODE genetics Announces First Quarter 2006 Financial Results Monday May 1, 4:1mopgcw-5/1/2006
223NYT: Schizophrenia as Misstep by Giant Gene By NICHOLAS WADE Published: April 1mopgcw-4/18/2006
222DCGN story in today's NYT: snipurl.comDewDiligence_on_SI-4/18/2006
221deCODE genetics Announces Full-year 2005 Financial Results Monday March 6, 4:08 mopgcw-3/6/2006
220deCODE Successfully Completes Phase I Clinical Program for DG041 for the Treatmenigel bates-2/21/2006
219Pharsight Builds Momentum in DMX(R) Product, Signs deCODE genetics MOUNTAIN VIEnigel bates-2/6/2006
218Didn't see Nigel beat me. (thanks.) eom.keokalani'nui-2/1/2006
217Thanks !nigel bates-2/1/2006
216DCGN :Look For Busy 1H:06 2006-01-10 05:55 (New York) Piper Jaffray & Co. mopgcw-2/1/2006
215deCODE Expands Cancer Program through Acquisition of Icelandic Cancer Research Gnigel bates-1/18/2006
214deCODE Discovers Major Genetic Risk Factor for Type 2 Diabetes Sunday January 15nigel bates-1/15/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News